This Article Full Text (PDF) Other Versions of this Article: AAC.01063-06v1 51/3/1055    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dover, L. G. Articles by Kremer, L. Search for Related Content PubMed PubMed Citation Articles by Dover, L. G. Articles by Kremer, L.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.01063-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets

School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. Laboratoire de Dynamique Moléculaire des Interactions Membranaires Normales et Pathologiques, UMR 5235 CNRS, Université de Montpellier II, case 107, Place Eugène Bataillon, 34095 Montpellier Cedex 05, France. Drug Discovery Division, Southern Research Institute, PO Box 55305, Birmingham, AL 35225-5305, USA

^* To whom correspondence should be addressed. Email: g.besra{at}bham.ac.uk. laurent.kremer{at}univ-montp2.fr.

	Abstract

Many of the current antimycobacterial agents require some form of cellular activation unmasking reactive groups, which in turn will bind to their specific targets. Therefore, understanding the mechanisms of activation of current antimycobacterials not only helps to decipher mechanisms of drug resistance but may also facilitate the development of alternative activation strategies or of analogs that do not require such processes. Herein, through the use of genetically-defined strains of M. bovis BCG we provide evidence that EthA, previously shown to activate ethionamide (ETH), also converts Isoxyl (ISO) and Thiacetazone (TAC) into reactive species. These results were further supported by the development of an in vitro assay using purified recombinant EthA, which allowed direct assessment of the metabolism of ISO. Interestingly, biochemical analysis of ¹⁴C-acetate-labeled cultures suggested that all of these EthA-activated drugs inhibit mycolic acid biosynthesis via different mechanisms through binding to specific targets. This report is also the first description of the molecular mechanism of action of TAC, a thiosemicarbazone antimicrobial agent that is still used in the treatment of tuberculosis as a second-line drug in many developing countries. Altogether, the results suggest that EthA is a common activator of thiocarbamide-containing drugs. The broad specificity of EthA can now be used to improve the activation process of these drugs, which may help overcome the toxicity problems associated with clinical thiocarbamide use.

This article has been cited by other articles:

• Weber, W., Schoenmakers, R., Keller, B., Gitzinger, M., Grau, T., Daoud-El Baba, M., Sander, P., Fussenegger, M. (2008). A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc. Natl. Acad. Sci. USA 105: 9994-9998 [Abstract] [Full Text]  
• Gratraud, P., Surolia, N., Besra, G. S., Surolia, A., Kremer, L. (2008). Antimycobacterial Activity and Mechanism of Action of NAS-91. Antimicrob. Agents Chemother. 52: 1162-1166 [Abstract] [Full Text]  
• Belanova, M., Dianiskova, P., Brennan, P. J., Completo, G. C., Rose, N. L., Lowary, T. L., Mikusova, K. (2008). Galactosyl Transferases in Mycobacterial Cell Wall Synthesis. J. Bacteriol. 190: 1141-1145 [Abstract] [Full Text]  
• Kordulakova, J., Janin, Y. L., Liav, A., Barilone, N., Dos Vultos, T., Rauzier, J., Brennan, P. J., Gicquel, B., Jackson, M. (2007). Isoxyl Activation Is Required for Bacteriostatic Activity against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51: 3824-3829 [Abstract] [Full Text]  
• Brown, A. K., Papaemmanouil, A., Bhowruth, V., Bhatt, A., Dover, L. G., Besra, G. S. (2007). Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II. Microbiology 153: 3314-3322 [Abstract] [Full Text]